W
WAVEMAN · COMPANY
TMO · Thermo Fisher Scientific Inc.
> Ask across nine datasets ⌘K
LIVE
TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475
← ALL COMPANIES

TMO

THERMO FISHER SCIENTIFIC INC.
MEDICAL DEVICES · MEASURING & CONTROLLING DEVICES, NEC · CIK 0000097745
CONGRESS · 1FORM 144 · 12☆ WATCH
INSIDER NET · 180D
-$62.5M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
1
FUNDS ADDED · QTR
1,134
13F, latest reported quarter
REVENUE GROWTH
+3.9%
XBRL, annual
NET MARGIN
15.0%
CONVERSIONS · 180D
12
codes C/M, not in net · $29.9M priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$62.5M over 180 days
-$61.6M over 90 days
below 95% of Medical Devices
CONGRESS
1 member bought in the last year
the lowest in Medical Devices
FUNDS
1,134 funds added or opened last quarter
the highest in Medical Devices
REVENUE
+3.9% year over year
below 62% of Medical Devices
MARGIN
15.0% net margin
more than 87% of Medical Devices
BUYBACKS
$4.0B repurchased, FY to 2026-06-27
the highest in Medical Devices
SHORT
no short interest reported
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$62.5M across 5 people in 180 days.
1,134 funds added or opened positions in the latest 13F quarter, of 2,622 holders.
1 member of Congress reported buying it this year.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN +26.4%
+26.4%12M
-10%+4%+18%+31%2025-092025-102025-122026-032026-052026-072026-09 2025-12-02 · Lagarde Michel sold $17.5M2025-12-03 · Lagarde Michel sold $17.2M2025-12-04 · Lagarde Michel sold $12.4M2026-08-11 · Shafer Michael D sold $8.6M2026-08-19 · Britt Lisa P. sold $7.0M2026-08-11 · Shafer Michael D sold $6.7M2025-11-25 · Shafer Michael D sold $5.1M2025-11-07 · Britt Lisa P. sold $4.8M2025-10-24 · CASPER MARC N sold $4.2M2025-12-01 · Lowery Frederick M. sold $4.1M2025-12-02 · Lowery Frederick M. sold $4.0M2026-08-06 · Britt Lisa P. sold $3.4M2025-11-13 · Lagarde Michel sold $2.8M2025-10-24 · CASPER MARC N sold $2.7M2026-08-31 · Pettiti Gianluca sold $2.3M2026-08-21 · CASPER MARC N sold $1.9M2026-08-21 · CASPER MARC N sold $1.7M2026-08-05 · CASPER MARC N sold $1.7M2026-08-20 · CASPER MARC N sold $1.6M2026-08-05 · CASPER MARC N sold $1.5M2025-12-03 · Lagarde Michel sold $1.5M2026-08-06 · CASPER MARC N sold $1.5M2025-10-27 · CASPER MARC N sold $1.4M2025-10-24 · CASPER MARC N sold $1.4M2025-11-25 · Shafer Michael D sold $1.4M2026-08-21 · CASPER MARC N sold $1.3M2025-11-10 · Pettiti Gianluca sold $1.3M2026-08-05 · CASPER MARC N sold $1.3M2026-08-06 · CASPER MARC N sold $1.2M2026-08-21 · CASPER MARC N sold $1.1M2025-11-07 · Britt Lisa P. sold $1,000.0K2026-08-06 · CASPER MARC N sold $933.6K2026-08-06 · CASPER MARC N sold $928.8K2026-08-20 · CASPER MARC N sold $903.8K2026-08-05 · CASPER MARC N sold $843.3K2026-08-20 · CASPER MARC N sold $824.7K2026-03-11 · Shafer Michael D sold $802.5K2026-08-20 · CASPER MARC N sold $787.3K2026-08-05 · CASPER MARC N sold $743.5K2025-10-24 · CASPER MARC N sold $743.5K2025-10-24 · CASPER MARC N sold $713.6K2026-03-04 · CASPER MARC N sold $701.2K2026-08-31 · Pettiti Gianluca filed to sell $2.5M2026-08-24 · CASPER MARC N filed to sell $172.4K2026-08-21 · CASPER MARC N filed to sell $6.3M2026-08-20 · CASPER MARC N filed to sell $6.3M2026-08-19 · Britt Lisa P. filed to sell $7.0M2026-08-11 · Shafer Michael D filed to sell $15.3M2026-08-07 · CASPER MARC N filed to sell $2.8M2026-08-07 · Holmes Joseph R. filed to sell $245.6K2026-08-06 · Britt Lisa P. filed to sell $3.4M2026-08-06 · CASPER MARC N filed to sell $8.7M2026-08-05 · CASPER MARC N filed to sell $8.5M2026-07-27 · Pettiti Gianluca filed to sell $226.0K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $62.5M sold by insiders over 180 days, 1,134 funds added last quarter, 1 Congress member(s) bought in 12 months, $61.4M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
PENROKBLFSMTDSIBNWRBYISRGTXGDXCMEWTMDXITRI
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, THERMO FISHER SCIENTIFIC INC. insiders sold a net $62.5M of stock across 904 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER
FILED
SHARES
VALUE
Pettiti Gianluca
President & COO
SELL
2026-08-31
400.0
$245.8K
Pettiti Gianluca
President & COO
SELL
2026-08-31
3,733.0
$2.3M
CASPER MARC N
Chairman & CEO
SELL
2026-08-24
101.0
$63.2K
CASPER MARC N
Chairman & CEO
SELL
2026-08-24
33.0
$20.7K
CASPER MARC N
Chairman & CEO
SELL
2026-08-24
79.0
$49.6K
904 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 899 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
30,919,632.0 sh
$15.5B
VANGUARD CAPITAL MANAGEMENT LLC
24,276,316.0 sh
$12.2B
STATE STREET CORP
16,825,879.0 sh
$8.4B
FMR LLC
14,084,488.0 sh
$7.1B
MORGAN STANLEY
10,763,066.0 sh
$5.4B
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Pettiti Gianluca
FILED 2026-08-31
$2.5M
CASPER MARC N
FILED 2026-08-24
$172.4K
CASPER MARC N
FILED 2026-08-21
$6.3M
CASPER MARC N
FILED 2026-08-20
$6.3M
Britt Lisa P.
FILED 2026-08-19
$7.0M
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Select Medical Technology and Devices Portfolio
$349.1M POSITION · AS OF 2026-02-28
9.6%
Eaton Vance Atlanta Capital Focused Growth Fund
$54.8M POSITION · AS OF 2026-03-31
8.5%
Large Cap Equity Fund
$37.5M POSITION · AS OF 2026-03-31
6.0%
Partners III Opportunity Fund
$17.2M POSITION · AS OF 2026-03-31
5.5%
Sofi Agentic Ai ETF
$486.2K POSITION · AS OF 2026-02-28
4.8%
Calvert Equity Fund
$180.1M POSITION · AS OF 2026-03-31
4.7%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 2 registered trials, 0 still enrolling or running — a status change here is dated weeks before the press release
2
Not applicable
0 ACTIVE
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Executive pay vs shareholder return · Mr. Casper
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2025
$79.9M
$116.1M
$7.6M
+26%
+57%
2024
$30.4M
$29.6M
$10.9M
+13%
+35%
2023
$19.0M
$9.2M
$5.5M
+15%
+28%
2022
$28.2M
-$4.7M
$5.9M
+19%
+22%
2021
$21.2M
$65.9M
$8.2M
+44%
+25%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$44.6B$42.9B$42.9B$44.9B
OPERATING INCOME$7.7B$7.3B$6.9B$8.4B
NET INCOME$6.7B$6.3B$6.0B$7.0B
EPS (DILUTED)17.7416.5315.4517.63
OPERATING CASH FLOW$7.8B$8.7B$8.4B$9.2B
CASH$9.9B$4.0B$8.1B$8.5B
LONG-TERM DEBT$39.2B$31.1B$34.7B$34.3B
BUYBACKS$3.0B$4.0B$3.0B$3.0B
DIVIDENDS PAID$636.0M$583.0M$523.0M$455.0M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-06 ALL SYSTEMS LIVE FOR MACHINES →